Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 12134 | 865 | 37.7 | 52% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 56 | 28576 | CHOLESTERYL ESTER TRANSFER PROTEIN//JOURNAL OF LIPID RESEARCH//HIGH DENSITY LIPOPROTEIN |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | NEPHROL ENDOCRINOL P | Address | 4 | 75% | 0% | 3 |
| 2 | GLYCATED LDL | Author keyword | 3 | 38% | 1% | 6 |
| 3 | GLYCATED APOLIPOPROTEIN B | Author keyword | 2 | 67% | 0% | 2 |
| 4 | DIABETIC SUBJECTS | Author keyword | 1 | 50% | 0% | 2 |
| 5 | TRANSVASCULAR LIPOPROTEIN TRANSPORT | Author keyword | 1 | 100% | 0% | 2 |
| 6 | LIPOPROTEIN COMPOSITION | Author keyword | 1 | 15% | 1% | 7 |
| 7 | AKT PATHWAYS | Author keyword | 1 | 50% | 0% | 1 |
| 8 | AMT TAG APPROACH | Author keyword | 1 | 50% | 0% | 1 |
| 9 | ANTIATHEROGENIC LIPOPROTEIN | Author keyword | 1 | 50% | 0% | 1 |
| 10 | CSSSG | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | GLYCATED LDL | 3 | 38% | 1% | 6 | Search GLYCATED+LDL | Search GLYCATED+LDL |
| 2 | GLYCATED APOLIPOPROTEIN B | 2 | 67% | 0% | 2 | Search GLYCATED+APOLIPOPROTEIN+B | Search GLYCATED+APOLIPOPROTEIN+B |
| 3 | DIABETIC SUBJECTS | 1 | 50% | 0% | 2 | Search DIABETIC+SUBJECTS | Search DIABETIC+SUBJECTS |
| 4 | TRANSVASCULAR LIPOPROTEIN TRANSPORT | 1 | 100% | 0% | 2 | Search TRANSVASCULAR+LIPOPROTEIN+TRANSPORT | Search TRANSVASCULAR+LIPOPROTEIN+TRANSPORT |
| 5 | LIPOPROTEIN COMPOSITION | 1 | 15% | 1% | 7 | Search LIPOPROTEIN+COMPOSITION | Search LIPOPROTEIN+COMPOSITION |
| 6 | AKT PATHWAYS | 1 | 50% | 0% | 1 | Search AKT+PATHWAYS | Search AKT+PATHWAYS |
| 7 | AMT TAG APPROACH | 1 | 50% | 0% | 1 | Search AMT+TAG+APPROACH | Search AMT+TAG+APPROACH |
| 8 | ANTIATHEROGENIC LIPOPROTEIN | 1 | 50% | 0% | 1 | Search ANTIATHEROGENIC+LIPOPROTEIN | Search ANTIATHEROGENIC+LIPOPROTEIN |
| 9 | DB PLUS MICE | 1 | 50% | 0% | 1 | Search DB++PLUS+MICE | Search DB++PLUS+MICE |
| 10 | DIABETIC LIPEMIA | 1 | 50% | 0% | 1 | Search DIABETIC+LIPEMIA | Search DIABETIC+LIPEMIA |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CHOLESTERYL ESTER SYNTHESIS | 6 | 33% | 2% | 15 |
| 2 | COMPOSITIONAL ABNORMALITIES | 4 | 75% | 0% | 3 |
| 3 | NONINSULIN DEPENDENT DIABETICS | 3 | 57% | 0% | 4 |
| 4 | APOLIPOPROTEIN B KINETICS | 3 | 42% | 1% | 5 |
| 5 | POSTHEPARIN PLASMA LIPOPROTEIN | 1 | 50% | 0% | 2 |
| 6 | TRIGLYCERIDE CONCENTRATIONS | 1 | 23% | 1% | 5 |
| 7 | NONENZYMATIC GLUCOSYLATION | 1 | 40% | 0% | 2 |
| 8 | NON ENZYMATIC GLYCATION | 1 | 25% | 0% | 3 |
| 9 | DENSITY LIPOPROTEIN TRIGLYCERIDE | 1 | 13% | 1% | 6 |
| 10 | ALKALINE REDUCING ACTIVITY | 1 | 50% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| LIPOPROTEIN METABOLISM IN DIABETES-MELLITUS | 1987 | 558 | 81 | 74% |
| LIPOPROTEIN PHYSIOLOGY IN NONDIABETIC AND DIABETIC STATES - RELATIONSHIP TO ATHEROGENESIS | 1991 | 196 | 124 | 56% |
| Management of dyslipidemia in adults with diabetes | 1998 | 230 | 192 | 26% |
| Lipoprotein glycation and its metabolic consequences | 1997 | 53 | 63 | 40% |
| HYPERLIPEMIA IN DIABETES | 1990 | 115 | 103 | 64% |
| LIPOPROTEIN DISORDERS IN DIABETES-MELLITUS | 1994 | 68 | 91 | 46% |
| Lipid disorders in type 1 diabetes | 2009 | 25 | 63 | 29% |
| Glycation as an atherogenic modification of LDL | 2008 | 26 | 73 | 30% |
| Lipid modification in type 2 diabetes: the role of LDL and HDL | 2009 | 19 | 35 | 29% |
| MANAGEMENT OF DYSLIPIDEMIA IN NIDDM | 1990 | 175 | 101 | 31% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NEPHROL ENDOCRINOL P | 4 | 75% | 0.3% | 3 |
| 2 | CSSSG | 1 | 50% | 0.1% | 1 |
| 3 | DIABET MOL RISK ASSESSMENT | 1 | 50% | 0.1% | 1 |
| 4 | FOOD QUAL HUMAN NUTR | 1 | 50% | 0.1% | 1 |
| 5 | INSERM U 539 | 1 | 50% | 0.1% | 1 |
| 6 | ISTANBUL MED INTERNAL MED | 1 | 50% | 0.1% | 1 |
| 7 | MED CLIN CHEM SECT | 1 | 50% | 0.1% | 1 |
| 8 | SERV ENDOCRINOL DIABETOL MALADIES METAB | 1 | 50% | 0.1% | 1 |
| 9 | VA TENNESSEE VALLEY GERIATR EDUC CLIN GRE | 1 | 50% | 0.1% | 1 |
| 10 | BIOCHEM BIOSTAT | 0 | 33% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000177134 | LIPOPROT UNIT//LIPOPROTEIN KINETICS//OURCE IL KINET ANAL |
| 2 | 0.0000130264 | GRADIENT GEL ELECTROPHORESIS//SMALL DENSE LDL//FAMILIAL COMBINED HYPERLIPIDEMIA |
| 3 | 0.0000118313 | CHYLOMICRON REMNANTS//POSTPRANDIAL LIPEMIA//CHYLOMICRON REMNANT |
| 4 | 0.0000097146 | DIABETES SPECIFIC FORMULA//HIGH MONOUNSATURATED FATTY ACID DIET//EARLY NEUROL REHABIL |
| 5 | 0.0000092323 | MULTIPLE CAUSE//CHRONIC COMPLICATIONS//DATASUS |
| 6 | 0.0000080693 | HYPERINSULINEMIA//SUGAR INDUCED HYPERTENSION//ATHEROSCLEROSIS METAB CLIN NUTR |
| 7 | 0.0000080124 | FRIEDEWALD FORMULA//NON HDL CHOLESTEROL//MIKE ROSENBLOOM CARDIOVASC |
| 8 | 0.0000078513 | ELECTRONEGATIVE LDL//ELECTRONEGATIVE LOW DENSITY LIPOPROTEIN//ENZYMATICALLY MODIFIED LDL |
| 9 | 0.0000075339 | COLD TARGET COMPETITION//COMPLEMENT DISTRIBUTION//DEFORMABILITY OF RED CELLS |
| 10 | 0.0000075330 | SEVERE HYPERTRIGLYCERIDEMIA//HYPERLIPIDEMIC PANCREATITIS//LIPEMIA RETINALIS |